872496-89-4

Basic information

• Product Name: 2-Propenoyl azide, 3-(3-methoxyphenyl)-, (2E)-
• CAS NO: 872496-89-4
• Molecular Formula: C10H9N3O2
• Molecular Weight: 203.2
• Mol File: 872496-89-4.mol
• Article Data: 12

Chemical Properties

• CAS DataBase Reference: 2-Propenoyl azide, 3-(3-methoxyphenyl)-, (2E)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Propenoyl azide, 3-(3-methoxyphenyl)-, (2E)-(872496-89-4)
• EPA Substance Registry System: 2-Propenoyl azide, 3-(3-methoxyphenyl)-, (2E)-(872496-89-4)

Safety Data

• Hazardous Substances Data: 872496-89-4(Hazardous Substances Data)

Upstream product

• 6099-04-3 trans-3-methoxycinnamic acid 
• 15851-92-0 (E)-3-methoxycinnamoyl chloride 

Downstream Products

• 1409964-75-5 4-bromo-1-chloro-6-methoxyisoquinoline 
• 923278-23-3 4-bromo-6-methoxyisoquinolin-1(2H)-one 
• 1418228-30-4 N-[(E)-2-(3-methoxyphenyl)vinyl]-N’-methyl urea 
• 1418228-26-8 C₁₁H₁₃NO₂ 
• 33543-63-4 ethyl-N-<2-(3-methoxyphenyl)ethyl>-carbamate 
• 26829-43-6 6-methoxy-2H-isoquinolin-1-one 
• 26829-43-6 6-methoxy-2H-isoquinolin-1-one 

Relevant articles and documents

Hepatitis C virus inhibitors

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

Synthesis of new N-(arylcyclopropyl)acetamides and N-(arylvinyl)acetamides as conformationally-restricted ligands for melatonin receptors

N-(Arylcyclopropyl)acetamides and N-(arylvinyl)acetamides or methyl ureas have been prepared as constrained analogues of melatonin. The affinity of these new compounds for chicken brain melatonin receptors and recombinant human MT1 and MT2 receptors was evaluated using 2-[ 125I]-iodomelatonin as radioligand. Strict ethylenic or cyclopropyl analogues of the commercialized agonist agomelatine (Valdoxan) were equipotent to agomelatine in binding bioassays. However, the ethylenic analogue was more effective than the cyclopropyl one in the melanophore aggregation bioassay, but was still less potent than the disubstituted 2,7-dimethoxy- naphtalenic compounds.

Hepatitis C Virus Inhibitors

Hepatitis C virus inhibitors having the general formula (I) are disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.